Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

If the drug is more broadly used in people with obesity and not just diabetes, those with higher body weights may see even ...

Berger Montague investigates Hims and Hers after stock drops 26% following Novo Nordisk's termination of GLP-1 drug partnership.

Experts have issued GPs with crucial guidance on weight loss jabs to avoid deadly complications, as the injections are ...

Supermarkets are selling fewer groceries thanks to an uptick in Brits taking weight-loss drugs including Wegovy and Mounjaro, ...

Eli Lilly is grabbing the lead in the fast-growing diabetes drug market. Eli Lilly (NYSE: LLY) has been on fire over the past ...

A large study led by researchers at Case Western Reserve University suggests that semaglutide—a drug already popular for ...

So-called ‘skinny jabs’ are being prescribed to people who don’t need them, with terrifying side effects. How did our ...

A blockbuster diabetes and weight-loss drug might be doing more than controlling blood sugar—it could also be protecting the ...

Wegovy is only approved for obesity in India. Novo Nordisk has no immediate plans to launch Ozempic for type 2 diabetes, ...

IT’S become one of the most popular weight loss drugs on the market, with pharmacies estimating that at least 1.5 million people in the UK are already using it. The jab, which is offered privately ...